REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F957. A total of 7 filers reported holding REGENERON PHARMACEUTICALS in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $80,686,000 | +12.0% | 2,198 | +22.7% | 4.69% | +73.9% |
| Q3 2016 | $72,042,000 | +77.8% | 1,792 | +54.5% | 2.70% | +27.7% |
| Q2 2016 | $40,511,000 | +91.1% | 1,160 | +97.3% | 2.11% | +99.4% |
| Q1 2016 | $21,194,000 | +759.8% | 588 | +1009.4% | 1.06% | +939.2% |
| Q3 2015 | $2,465,000 | -94.7% | 53 | -94.2% | 0.10% | -94.0% |
| Q2 2015 | $46,269,000 | +77.0% | 907 | +56.6% | 1.69% | +55.1% |
| Q1 2015 | $26,141,000 | -51.6% | 579 | -69.7% | 1.09% | -53.0% |
| Q2 2014 | $54,037,000 | +38.5% | 1,913 | +47.3% | 2.32% | +5.9% |
| Q1 2014 | $39,006,000 | +14084.0% | 1,299 | +12890.0% | 2.19% | +12050.0% |
| Q4 2013 | $275,000 | -95.2% | 10 | -94.5% | 0.02% | -95.1% |
| Q3 2013 | $5,694,000 | -55.3% | 182 | -67.9% | 0.37% | -56.5% |
| Q2 2013 | $12,751,000 | – | 567 | – | 0.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Garda Capital Partners LP | 7,500 | $5,411,175 | 0.30% |
| SIMPLEX TRADING, LLC | 56,000 | $40,403 | 0.04% |
| GROUP ONE TRADING, L.P. | 19,600 | $14,141,204 | 0.03% |
| JANE STREET GROUP, LLC | 74,800 | $53,967,452 | 0.02% |
| IMC-Chicago, LLC | 22,200 | $16,017,078 | 0.02% |
| Twin Tree Management, LP | 6,900 | $4,978,281 | 0.01% |
| Maven Securities LTD | 500 | $360,745 | 0.01% |
| Allianz Asset Management GmbH | 3,500 | $2,525,215 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 3,600 | $2,597 | 0.00% |